Cystic fibrosis (CF) was once known as a fatal disease of childhood, but now with advances in cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapies, anti‐infective, and airway clearance regimens, children born between 2020 and 2024 have a median predicted life expectancy of 65 years, nearly doubling over the life expectancy over the past two decades [1, 2, 3, 4, 5]. Here, CFTR is linked to cystic fibrosis.